Cedar Wealth Management, LLC Eli Lilly & CO Transaction History

Cedar Wealth Management, LLC

$290 Million
Q2 2025

A detailed history of Cedar Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cedar Wealth Management, LLC holds 266 shares of LLY stock, worth $217,955. This represents 0.07% of its overall portfolio holdings.

Number of Shares

266

Previous 259 2.7%

Holding current value

$217,955

Previous $213,000 2.82%

% of portfolio

0.07%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$713.71 - $898.95 $4,995 - $6,292	7 Added 2.7%	266 $207,000
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $135,124 - $168,003	-175 Reduced 40.32%	259 $229,000
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $22,470 - $28,180	-31 Reduced 6.67%	434 $392,000
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $15,397 - $20,599	26 Added 5.92%	465 $361,000
Q3 2023 Oct 27, 2023	SELL	$434.7 - $599.3 $204,309 - $281,671	-470 Reduced 51.71%	439 $235,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $108,720 - $127,687	-350 Reduced 27.8%	909 $312,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $131,835 - $153,614	-410 Reduced 24.57%	1,259 $460,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $889 - $1,013	-3 Reduced 0.18%	1,669 $540,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $105,917 - $124,362	-380 Reduced 18.52%	1,672 $542,000
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $18,775 - $23,332	-80 Reduced 3.75%	2,052 $588,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $54,413 - $67,527	242 Added 12.8%	2,132 $589,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $90,636 - $117,237	-502 Reduced 20.99%	1,890 $434,000
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $62,441 - $80,833	-380 Reduced 13.71%	2,392 $447,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $81,798 - $108,239	-627 Reduced 18.45%	2,772 $468,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $4,679 - $5,412	32 Added 0.95%	3,399 $503,000
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 2.88%	3,367 $553,000
Q1 2020 May 01, 2020	SELL	$119.05 - $147.35 $117,145 - $144,992	-984 Reduced 22.11%	3,467 $481,000
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $73,667 - $91,244	-689 Reduced 13.4%	4,451 $585,000
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $46,987 - $51,110	-440 Reduced 7.89%	5,140 $575,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $23,155 - $27,027	-209 Reduced 3.61%	5,580 $618,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $108,082 - $127,220	-971 Reduced 14.36%	5,789 $751,000
Q4 2018 Jan 23, 2019	SELL	$105.9 - $118.64 $13,237 - $14,830	-125 Reduced 1.82%	6,760 $782,000
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $60,102 - $75,117	-700 Reduced 9.23%	6,885 $739,000
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $3,633 - $4,170	48 Added 0.64%	7,585 $647,000
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $36,733 - $43,362	495 Added 7.03%	7,537 $583,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $6,555 - $7,031	80 Added 1.15%	7,042 $595,000
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $536,561 - $595,529	6,962	6,962 $596,000

Others Institutions Holding LLY

# of Institutions

4,448

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Wealth Management, LLC with notifications on news.

Account

Cedar Wealth Management, LLC Eli Lilly & CO Transaction History